(:LSAQ)

Oct 07, 2021 08:00 am ET
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
Science 37, Inc., the Operating System for today’s agile clinical trials, announced today that it has completed its previously announced business combination with LifeSci Acquisition II Corp. (NASDAQ: LSAQ) (“LifeSci”), a blank check company...
Jun 16, 2021 09:00 am ET
LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company formed for the purpose of pursuing targets that are focused on healthcare innovation, today announced the confidential submission with the U.S. Securities and Exchange Commission...
May 12, 2021 10:15 am ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger
Rigrodsky Law, P.A. announces that it is investigating LifeSci Acquisition II Corp. (“LifeSci”) (NASDAQ GS: LSAQ) regarding possible breaches of fiduciary duties and other violations of law related to LifeSci’s agreement to merge with Science 37,...
May 11, 2021 05:03 pm ET
Moore Kuehn Encourages MNR, LOKB, LSAQ and MFNC Investors to Contact Law Firm
Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek...
Nov 20, 2020 01:50 pm ET
LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering
LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering of 7,500,000 shares at $10.00 per share. The shares will begin trading today on the NASDAQ...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.